Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NENT Group tops Nordic Business Diversity Index

· NENT Group ranked number one in Stockholm Nasdaq Large Cap Companies and TMT (all Nordics) categories · Nordic Business Diversity Index measures diversity of boards and executive management · NENT Group has a 50/50 gender split in senior leaders reporting to CEO Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, has been ranked number one in the Nordic Business Diversity Index in both the Stockholm Nasdaq Large Cap Companies and TMT (all Nordics) categories. The Nordic Business Diversity Index measures the diversity of boards and executive

BioArctic receives European patent for new antibodies targeting Alzheimer’s disease

Stockholm, January 27, 2021 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the European Patent Office (EPO) has issued a decision to grant European patent EP 2 448 968 B1 for novel antibodies that could be developed into a treatment for Alzheimer’s disease. The antibodies target a shorter (truncated) form of amyloid beta (pE3-Aβ) and are linked to the company’s project AD1503. The patent enters into force on 27 January 2021 and expires in 2030. BioArctic’s newly granted patent focuses on novel antibodies which target pE3-Ab, a specific truncated form of amyloid

Proposal regarding the Board of Directors

Castellum has received a proposal regarding the composition of the Board of Directors from Stichting Pensioenfonds ABP, the second largest shareholder in Castellum, and two members of the Election Committee, Vincent Fokke, representing Stichting Pensioenfonds ABP, and Charlotte Strömberg, Chair of the Board of Castellum. The election of the Board of Directors will take place at the Annual General Meeting to be held on March 25, 2021.Proposal regarding the composition of the Board The purpose of this proposal is to ensure a Board of Directors of Castellum that is both competent and

SBB increases focus on housing for the elderly

Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) intends to double the value of properties for housing for the elderly in the Nordic region within two years to approximately SEK 20 billion. In the current property portfolio, the Swedish tenants are 75 per cent public actors with an average lease period of just over seven years. As part of the acquisition of Sveafastigheter, Magnus Edlund will transfer to SBB in a new role as Head of Business Development for Elderly Care Housing. Magnus has over 30 years of experience from the real estate industry in senior positions with institutional

Q-Free: Acceptances received under mandatory offer to acquire all shares in Q-Free ASA

The Offer is not being made, and this press release may not be distributed, directly or indirectly, in or into, nor will any tender of shares be accepted from or on behalf of holders in, any jurisdiction in which the making of the Offer, the distribution of this stock exchange announcement or the acceptance of any tender of shares would contravene applicable laws or regulations. (Oslo, 27 January 2021): Reference is made to the mandatory offer (the “Offer”) from Rieber & Søn AS (the “Offeror”) to acquire all shares in Q-Free ASA (“Q-Free” or the “Company”) pursuant to an offer document

Orexo strengthens IP rights for overdose rescue drug OX124

· Patent protection until 2039 · Previous human pharmacokinetic (PK) study showed significantly better PK profile when compared to market leading product Uppsala, Sweden – January 27, 2021 – Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces that the company has further strengthened the intellectual property (IP) for its flagship pharmaceutical pipeline asset OX124, a naloxone rescue medication for the treatment of opioid overdose. The US Patent and Trademark Office (USPTO) has issued a new patent protecting the product until 2039. The new patent, US 10,898,480, is the

Hansa Biopharma to host conference call to provide Year-End report 2020 and Business Update

Lund, Sweden January 27, 2021. Hansa Biopharma will publish its Year-End report 2020 at 8:00 CET on February 4, 2021. All interested parties are invited to participate in a telephone conference, which will include a presentation of the interim results and a business update, on the same date at 14:00 CET/2:00pm EST. The event will be hosted by Hansa Biopharma’s CEO, Søren Tulstrup, and CFO, Donato Spota, and the presentation will be held in English. Slides used in the presentation will be live on the company website during the call under “Events & Webcast,” and will also be made

Increased sales and profitability in 2020 during a challenging fourth quarter

January - December · Net sales increased +0.8 percent to SEK 310.1 (307.6) million (+3 percent in local currencies). · EBIT was SEK 28.6 (6.2) million. · The EBIT margin was 9.1 (2.0) percent. · Profit after tax amounted to SEK 16.3 (4.9) million. · Earnings per share before/after dilution amounted to SEK 0.88 (0.28). · Cash flow from operating activities amounted to SEK 52.0 (17.7) million. · Cash and cash equivalents at the end of the period amounted to SEK 101.2 (63.9) million. Fourth quarter · Net sales declined -20.6 percent to SEK 66.7 (84.0) million (-

Divio announces that an additional contract for a Support Service Level Agreement is signed with Fidelity International

Divio Technologies AB (publ) today announced that investment and retirement savings provider Fidelity International has increased its engagement with Divio. This additional commitment takes the form of a Support Service Level Agreement, and entails an additional recurring monthly revenue of USD 43’200.Divio has enjoyed a long-term relationship with Fidelity International, a partnership that has strengthened and deepened over the years. As well as its adoption of Divio’s cloud management platform, Fidelity International uses Divio as a strategic technology partner providing expertise. In

Nationalarenan 3 – Scandinavia’s first ‘Plushus’ hotel

Scandinavia’s first zero-energy hotel, Nationalarenan 3 in Arenastaden, is now in the final stages of completion. The building produces as much energy as it consumes, and has now achieved FEBY ‘Gold Plushus’ certification. FEBY’s purpose as an organisation is to increase and develop energy-efficient construction.Nationalarenan 3 is a unique project that aims to meet ambitious sustainability targets, while calling on the industry as a whole to build more sustainably. Some 25 geothermal energy boreholes along with a total of almost 2,500 sqm of solar panels on the facade and roof produce more

Delete Group Oyj announces status and tentative timeline of the restructuring measures

Delete Group Oyj, Stock Exchange Release 27 January 2021 at 8.30 EETNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. As announced by Delete Group Oyj ("Delete" or the "Issuer") on 16 December 2020, Delete has, together with its financial adviser, ABG Sundal Collier ASA, initiated certain restructuring measures (the "Restructuring Measures"). On 15 January 2021, Delete announced that the holders of its secured fixed rate notes due 2021 (ISIN

SEB revises financial targets to support customers through increased financial flexibility

SEB’s Board of Directors has revised the financial targets for the group, with the objective to create further financial flexibility to better support the bank’s customers over time. According to the new targets, the bank will maintain a Common Equity Tier 1 capital ratio of 100-300 basis points above the regulatory requirement and pay a yearly dividend of around 50 per cent of earnings per share, and distribute potential capital in excess of the targeted capital position mainly through share repurchases.SEB’s financial targets, with effect from 2021, are: · To pay a yearly dividend

BERGENBIO ASA: INVITATION TO FOURTH QUARTER 2020 RESULTS

Bergen, Norway, 27 January 2021 – BerGenBio ASA (OSE:BGBIO), a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical need, will be announcing its results for the fourth quarter 2020 on Wednesday 10 February 2021. A webcast presentation by BerGenBio’s senior management team will take place at 10:00 am CET.  The live webcast link will be available at www.bergenbio.com in the Investors/Financial Reports section. A recording will be available shortly after the webcast has finished.  The fourth quarter report and presentation

Year-end Report 2020

JANUARY 1 – DECEMBER 31, 2020(compared with the corresponding period a year ago) · Highest adjusted EBITA and highest adjusted EBITA margin ever · Target raised for adjusted return on capital employed to above 17% by 2025 · Net sales declined 5.6% to SEK 121,752m (128,975) · Organic net sales declined 1.9% · Sales were negatively impacted by the COVID-19 pandemic and related lockdowns · In emerging markets, which accounted for 37% of net sales, organic net sales increased 2.6% · Operating profit before amortization of acquisition-related intangible assets (EBITA)

SEB's year-end report

The operating profit for the fourth quarter 2020 amounted to SEK 6.4bn with a return on equity of 12.2 per cent and a Common Equity Tier 1 capital ratio of 21 per cent. The operating profit for 2020 amounted to SEK 19.8bn with a return on equity of 9.7 per cent. The Board of Directors proposes a dividend of SEK 4.10 per share."Throughout the year, our financial strength has enabled us to support our customers. Despite the challenging economic environment, SEB’s business model proved resilient during the year, delivering operating income in local currencies that was broadly unchanged

Aker Offshore Wind enters cooperation agreement with Statkraft

Aker Offshore Wind Operating Company AS (“Aker Offshore Wind”) and its majority owner Aker Horizons AS (“Aker Horizons”) have entered into a cooperation agreement with Statkraft AS (“Statkraft”) to explore possibilities for collaboration on offshore wind power projects on the Norwegian Continental Shelf (“NCS”).Aker Horizons, Aker Offshore Wind and Statkraft (the “Parties”) will work together and utilize their complementary skills and expertise to explore the possibility to develop and operate large-scale offshore wind parks in Norway. By harnessing excellent offshore wind resources in the

Qiiwi Games completes a heavily over-subscribed directed new share issue of 1,000,000 new shares, raising proceeds of approximately SEK 66.5 million

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE REFER TO IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASE. Qiiwi Games AB (publ) (”Qiiwi Games” or the ”Company”) has, as communicated in the Company’s press release earlier today, resolved on and carried out a directed new share

ShaMaran Proposal to Bondholders Approved

VANCOUVER, BC, January 26, 2021 /CNW/ - ShaMaran Petroleum Corp. ("ShaMaran" or the "Company") (SNM - TSXV, Nasdaq First North Growth Market) provides the following update to stakeholders in connection with the Company’s news release dated January 12, 2021 regarding the Proposal that was submitted to the Bondholders relating to the Company’s 12% senior unsecured bonds due 2023 (ISIN: NO 001082645.6). ShaMaran is pleased to announce that the Proposal has been approved with the full support of all of the Bondholders voting on the Proposal.  This approval will permit the Company to use its “

Notice of Extra General Meeting in Bambuser AB

The shareholders of Bambuser AB, reg. no. 556731-3126, (the "Company"), are hereby convened to the extra general meeting to be held on Friday 12 February 2021, at 10.00 at Baker McKenzie's premises at Vasagatan 7 in Stockholm. Information with respect to the coronavirusDue to the development of the coronavirus the goal is that the extra general meeting shall be swift and effective to minimize spread of disease. Shareholders should carefully consider the possibility to vote in advance, please see below, as well as the possibility of participating by way of proxy or video. Shareholders

Lucara Recovers 378 Carat Top White Gem Diamond from the Karowe Mine in Botswana

VANCOUVER, January 26, 2021 /CNW/ - (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) is pleased to announce another recovery of significance from its 100% owned Karowe Mine. A magnificent unbroken Type IIa 378 carat gem quality top white diamond was recently recovered from milling of ore sourced from the M/PK(S) unit of the South Lobe (image attached ).  This recovery is the 2[nd] +300 carat gem quality diamond to be recovered this year from direct milling

Enviro receives order from Michelin for engineering services worth MSEK 4

Scandinavian Enviro Systems (publ) (“Enviro” or “The Company”) has received an order from Michelin for engineering services and technical documentation at a value of approximately SEK 4 million (EUR 400 000).N.B. The English text is an in-house translation of the original Swedish text. Should there be any disparities between the Swedish and the English text, the Swedish text shall prevail. The order includes engineering services as well as documentation of Enviro’s patented technology for material recovery of end-of-life-tyres (ELT) and form a basis for the negotiations about a strategic

Bambuser has completed a directed share issue raising proceeds of approximately MSEK 500

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE THE RELEASE, DISTRIBUTION OR PUBLICATION OF THIS PRESS RELEASE WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES INSIDE INFORMATION: Bambuser AB (”Bambuser” or the ”Company”) has, as announced in the Company’s press release earlier today, successfully completed a directed issue of 32,250,000 shares (the “Directed Issue”). The

Calliditas Therapeutics launches proposed global offering

January 26, 2021 Calliditas Therapeutics AB (publ) (“Calliditas”) (Nasdaq OMX – CALTX; Nasdaq – CALT) will today launch a proposed public offering of American Depositary Shares ("ADSs"), in the United States for trading on The Nasdaq Global Select Market in the United States (the “U.S. Offering”) and a concurrent private placement of common shares to certain qualified investors in Europe and other countries outside of the United States (the "Private Placement”, and together with the U.S. Offering, the “Global Offering”). The target size of the Global Offering is 4,500,000 common shares

There are no items matching the current filter
There are no more items matching the current filter
Back to top